Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, not just today’s reading.
Reader sentiment, not investment advice. One vote per visitor; click again to change it.
Concentra Group (CON) is trading at $36.21, up 1.57% on the day. Its market value of $4.62B makes it the 2164th largest of the 3132 companies we follow.
Over a full year the shares have ranged across $18.36 to $36.71, which puts the current price roughly 97% of the way up that band. Holders are ahead 77.2% over twelve months, and up 14.7% across the last three months.
On the chart it holds above both the 50-day ($34.21) and 200-day ($26.63) moving averages; RSI is 62, and the last 30 sessions moved at roughly 22% annualized volatility.
Revenue for ANNUAL, ended Dec 2025 was $2.16B, up 13.9% from a year earlier, with $172.85M of net profit (a 8.0% margin).
Valuation works out to 23.4 times trailing earnings, 34% above its five-year average of 17.4. The median for its industry group is 21.6.
10 analysts follow the stock and the average call is "buy". The mean target, $41.00, sits 13.2% over where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Composite of 4 factors below, ranked against the 3132 U.S. stocks BeStock covers.
Cheaper than usual on its own 5-year P/E history scores higher.
Higher trailing yield than most of BeStock’s coverage scores higher.
Trading closer to its 52-week high than most peers scores higher.
10 analysts, consensus Buy.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
CON is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2021-01-04, the strategy has returned 389% (231.1% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.
What Wall Street analysts and Morningstar's fair-value model expect for the stock
Wall Street’s average 12-month target is $41.00, 13.2% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $34.22, so shares trade 5.8% above that estimate. On earnings multiple, it sits in the 99th percentile of its own five-year valuation range (pricier than usual).
Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.
Price return over each window, from adjusted daily and weekly closes
| Indicator | Value | Signal |
|---|---|---|
| Price vs 20-day average | +3.2% | Bullish |
| Price vs 50-day average | +5.9% | Bullish |
| Price vs 200-day average | +36.0% | Bullish |
| 50-day vs 200-day | 50d above 200d | Bullish |
| RSI (14) | 62.0 | Bullish |
| MACD (12,26,9) | 0.36 | Bullish |
| Bollinger band position | 92% | Bullish |
Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.
Quote as of Oct 6, 2026 1:00 am ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 3,132 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
Set against the peer table: at 23.4x earnings, CON looks about mid-pack against the market, and trades 8% above the 21.6x median among Medical Care Facilities names. The two comparisons do not always agree.
$36.21 is the latest print for CON, a move of +1.57% against yesterday's close of $35.65. Today's low and high so far: $35.48 and $36.51.
Equity value comes to $4.62B at the current price. By that measure it is number 2164 of the 3132 names in our coverage.
Buyers pay 23.4 times the last twelve months of profit (EPS $1.30). Averaged over five years the multiple has been 17.4, and today's level ranks in the 99th percentile of its own history.
The year's floor is $18.36 and the ceiling $36.71. Shares are 1.4% away from that ceiling.
It does. Payouts over the past twelve months work out to a 0.69% yield; the latest ex-dividend date was August 20, 2026.
Of 10 analysts, 90% say buy, 10% hold and 0% sell. Price targets average $41.00, with the most cautious at $40.00 and the most optimistic at $43.00.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on CON.